Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jeffrey Trocio, Virginia M Rosen, Anu Gupta, Oluwaseyi Dina, Lien Vo, Patrick Hlavacek & Lisa Rosenblatt. (2019) Systematic literature review of treatment patterns for venous thromboembolism patients during transitions from inpatient to post-discharge settings. ClinicoEconomics and Outcomes Research 11, pages 23-49.
Read now
Read now
Fabio Fabbian, Alfredo De Giorgi, Ruana Tiseo, Beatrice Zucchi & Roberto Manfredini. (2016) Reducing the risk of venous thromboembolism using apixaban – patient perspectives and considerations. Should more attention be given to females?. Patient Preference and Adherence 10, pages 73-80.
Read now
Read now
Alpesh Amin, Amanda Bruno, Jeffrey Trocio, Jay Lin & Melissa Lingohr-Smith. (2015) Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US. Journal of Medical Economics 18:6, pages 399-409.
Read now
Read now
Articles from other publishers (11)
Siwaporn Niyomsri, Mantiwee Nimworapan, Wanwarang Wongcharoen & Piyameth Dilokthornsakul. (2023) Economic Evaluation of Direct Oral Anticoagulants Compared to Warfarin for Venous Thromboembolism in Thailand: A Cost-Utility Analysis. International Journal of Environmental Research and Public Health 20:4, pages 3176.
Crossref
Crossref
Kevin M. Wheelock, Joseph S. Ross, Karthik Murugiah, Zhenqiu Lin, Harlan M. Krumholz & Rohan Khera. (2021) Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries. JAMA Network Open 4:12, pages e2137288.
Crossref
Crossref
Thomas L. Ortel, Ignacio NeumannWalter AgenoRebecca Beyth, Nathan P. Clark, Adam Cuker, Barbara A. Hutten, Michael R. Jaff, Veena Manja, Sam SchulmanCaitlin ThurstonSuresh VedanthamPeter VerhammeDaniel M. Witt, Ivan D. Florez, Ariel Izcovich, Robby NieuwlaatStephanie RossHolger J. Schünemann, Wojtek Wiercioch, Yuan ZhangYuqing Zhang. (2020) American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Advances 4:19, pages 4693-4738.
Crossref
Crossref
Mohammad Al Mukdad, Daoud Al-Badriyeh & Hazem Fathy Elewa. (2019) Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review. Clinical and Applied Thrombosis/Hemostasis 25, pages 107602961984910.
Crossref
Crossref
Lisa A. de Jong, Evgeni Dvortsin, Kristel J. Janssen & Maarten J. Postma. (2017) Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands. Clinical Therapeutics 39:2, pages 288-302.e4.
Crossref
Crossref
Heike EndigFranziska MichalskiJan Beyer-Westendorf. (2016) Deep Vein Thrombosis – Current Management Strategies. Clinical Medicine Insights: Therapeutics 8, pages CMT.S18890.
Crossref
Crossref
Zachary A. StacySara K. Richter. (2016) The Use of Edoxaban in Patients with Nonvalvular Atrial Fibrillation and Venous Thromboembolism: A Pharmacist's Perspective. Hospital Pharmacy 51:1, pages 26-34.
Crossref
Crossref
Alpesh Amin, Amanda Bruno, Jeffrey Trocio, Jay Lin & Melissa Lingohr-Smith. (2015) Real-World Medical Cost Avoidance When New Oral Anticoagulants are Used Versus Warfarin for Venous Thromboembolism in the United States. Clinical and Applied Thrombosis/Hemostasis 22:1, pages 5-11.
Crossref
Crossref
Alpesh Amin, Amanda Bruno, Jeffrey Trocio, Jay Lin & Melissa Lingohr-Smith. (2015) Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States. Journal of Managed Care & Specialty Pharmacy 21:10, pages 965-972.
Crossref
Crossref
Geno Merli, Brian Hiestand, Alpesh Amin, Anthony Macchiavelli, Adam Singer & Charles Pollack. (2015) Balancing Anti-thrombotic Efficacy and Bleeding Risk in the Contemporary Management of Venous Thromboembolism. Current Emergency and Hospital Medicine Reports 3:2, pages 89-99.
Crossref
Crossref
Mashio Nakamura, Masakatsu Nishikawa, Issei Komuro, Isao Kitajima, Yoshio Uetsuka, Takuji Yamagami, Hiroki Minamiguchi, Rika Yoshimatsu, Kosuke Tanabe, Nobushige Matsuoka, Kazuhiro Kanmuri & Hisao Ogawa. (2015) Apixaban for the Treatment of Japanese Subjects With Acute Venous Thromboembolism (AMPLIFY-J Study). Circulation Journal 79:6, pages 1230-1236.
Crossref
Crossref